MDMA Statement on House Legislation to Change the U.S. Patent System
Washington, D.C. – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today regarding legislation introduced in the House of Representatives to change the patent system:
“MDMA supports balanced and reasonable steps to curb abusive ‘patent trolls,’ but not in a manner that would thwart the development of medical treatments and the lifesaving technologies of tomorrow. The proposed legislation would have the unintended consequences of weakening the patent rights of innovators, and perhaps most tragically, stifle future investments in promising therapies that would improve the human condition.
“It is crucial that the voices of innovators, start-ups and universities are heard and that changes to our nation’s patent system don’t punish patient care and job creation. MDMA remains committed to working with Members of the Judiciary Committee and the entire Congress to ensure that any legislation that puts an end to the abuses of ‘patent trolls’ doesn’t inadvertently harm innovation.”